Mimics and challenging presentations of DADA2
- PMID: 40117338
- PMCID: PMC12062958
- DOI: 10.1093/cei/uxaf017
Mimics and challenging presentations of DADA2
Abstract
Deficiency of adenosine deaminase 2 (DADA2) has been a challenging diagnosis to make since it was first described in 2014. The disease represents a wide range of phenotypes. Therefore, it may present with various clinical patterns. Throughout the years, several difficult-to-diagnose cases of DADA2 were reported in the literature. Although several studies and reviews were published regarding different phenotypes and manifestations of DADA2, a review of challenging cases with diverse combinations of DADA2 manifestations was needed to integrate the knowledge from the literature into the clinical practice. Immunological, hematologic, autoinflammatory, and adult-onset polyarteritis-nodosa patterns were reported in the literature as cases challenging to diagnose. In this review, we aim to summarize the challenging case reports from the literature, provide an algorithmic approach for these kinds of presentations, and share our perspective and recommendations on the topic. Diagnosing DADA2 on time is a vital issue for preventing fatal and debilitating vascular events with anti-TNF-alpha therapy. Thus, early testing for DADA2 in suspected cases is recommended. Family history and genetic testing of the patient and the first-degree relatives are essential for accurate diagnosis. Thorough systemic examination and imaging might help detect clinically silent findings of vasculitis. Enzymatic activity of ADA2, when available, is also a key diagnostic tool that complements genetic testing and clinical evaluation.
Keywords: autoinflammatory disease; immunodeficiency diseases; inflammation; vasculitis.
© The Author(s) 2025. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
The authors declare no competing interests.
References
-
- Signa S, Bertoni A, Penco F, Caorsi R, Cafaro A, Cangemi G, et al.Adenosine deaminase 2 deficiency (DADA2): a crosstalk between innate and adaptive immunity. Front Immunol 2022, 13, 935957. doi: https://doi.org/10.3389/fimmu.2022.935957. - DOI - PMC - PubMed
-
- Sharma V, Deo P, Sharma A.. Deficiency of adenosine deaminase 2 (DADA2): review. Best Pract Res Clin Rheumatol 2023, 37, 101844. doi: https://doi.org/10.1016/j.berh.2023.101844 - DOI - PubMed
-
- Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, et al.Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 2014, 370, 921–31. doi: https://doi.org/10.1056/NEJMoa1307362 - DOI - PubMed
-
- Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al.Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 2014, 370, 911–20. doi: https://doi.org/10.1056/NEJMoa1307361 - DOI - PMC - PubMed
-
- Meyts I, Aksentijevich I.. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol 2018, 38, 569–78. doi: https://doi.org/10.1007/s10875-018-0525-8 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials